✦ LIBER ✦

Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy

✍ Scribed by Jurriën G.P. Reijnders; Suzan D. Pas; Martin Schutten; Robert A. de Man; Harry L.A. Janssen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

645 VIROLOGICAL RESPONSE AT 12 WEEKS OF

✍ B.-C. Song; H.B. Chae; Y.N. Kim; B.S. Lee; Y.-K. Cho 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Long-term impact of entecavir monotherap

✍ Ko, Soon Young; Choe, Won Hyeok; Kwon, So Young; Kim, Jeong Han; Seo, Jung Woong 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 155 KB

Efficacy and safety of telbivudine plus

✍ Lu, Jia-Jie; Liu, Kai; Ma, Yuan-Ji; Wang, Juan; Chen, En-Qiang; Tang, Hong 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Combination of Lamivudine and adefovir t

✍ L.-C. Wang; E.-Q. Chen; J. Cao; L. Liu; J.-R. Wang; B.-J. Lei; H. Tang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

[524] PREDICTORS OF RESPONSE IN PATIENTS

✍ J. Li; H. Zhao; C.-W. Si; Y.-X. Zhang; X.-Y. Chen; L. Wang; X.-P. Tang 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 244 KB

Entecavir Therapy for up to 96 Weeks in

✍ Robert G. Gish; Anna S. Lok; Ting–Tsung Chang; Robert A. de Man; Adrian Gadano; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 303 KB